India  

Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin

Video Credit: HT Digital Content - Duration: 01:43s - Published
Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin

Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin

Haryana Health Minister Anil Vij was administered a trial dose of Covaxin on Friday.

67-year old Vij was administered the trial dose at the Civil Hospital at Ambala Cantt.

On Wednesday, Vij had said the third phase of trial will begin in Haryana on Nov 20.

Vij, an MLA from Ambala Cantt, had offered to be the first volunteer to get vaccinated.

Covaxin, a potential vaccine against Covid, entered third phase of clinical trial.

Covaxin is being developed indigenously by Bharat Biotech in collaboration with ICMR. Last month, the vaccine maker said it had completed interim analysis of Phase 1, 2 trials.

The phase 3 trials will involve 26,000 volunteers across 25 centres in India.

It is the largest clinical trial conducted for a Covid-19 vaccine in India.


You Might Like


💡 newsR Knowledge: Other News Mentions

Anil Vij Anil Vij Indian politician

COVID-19: Will not 'need' a second shot of vaccine, says Haryana Health Minister Anil Vij due to this reason

Haryana Health Minister Anil Vij on Monday said that he will not 'need' a second shot of the COVID-19 vaccine.
DNA

Haryana Haryana State in northern India

Farmers mark 100 days of protest against new farm laws, block expressway: Highlights

Farmers protesting the Centre's three new farm laws on Saturday blocked the six-lane Kundli-Manesar-Palwal (KMP) Expressway at some places in Haryana to mark the..
IndiaTimes

Farmers evolve rotation strategy to balance protests and farming

The season for harvesting crops is arriving next month and the agitating farmers from Punjab and Haryana have devised a "rotational" strategy to deal with the..
IndiaTimes

Elderly farmers lead the way in KMP Expressway protest

Braving the scorching heat, elderly farmers formed the majority of protesters at Haryana's Palwal toll plaza on the Kundli-Manesar-Palwal (KMP) Expressway. Many..
IndiaTimes
Pregnant cow ingested 70 kg waste, calf could not grow | Oneindia News [Video]

Pregnant cow ingested 70 kg waste, calf could not grow | Oneindia News

In a shocking development that highlights India's pollution and stray cattle problem, veterenarians in Haryana's Faridabad have extracted about 70 kgs of waste from a pregnant cow. The vets noticed the cow struggling and decided to undertake a surgery when they discovered 70 kgs of plastic, iron nail, marble and other waste in the cow's stomach. #StrayCow #IndiaPollution #SacredCow

Credit: Oneindia    Duration: 01:19Published
Vets extract over 70kg waste in stray pregnant cow's stomach in Faridabad [Video]

Vets extract over 70kg waste in stray pregnant cow's stomach in Faridabad

Veterinarians in Haryana's Faridabad extracted over 70 kilograms of plastic, iron materials and other garbage from a pregnant cow, but both the animal and her baby died. The pregnant cow was rescued after it met with an accident, it underwent abortion later. This case has highlighted the country's twin problems of pollution and stray cattle. "A pregnant cow was rescued after it met with an accident, it underwent abortion later. We operated the animal and removed over 70 kgs of garbage from its body including plastic, glass and iron materials. However, we couldn't save it," said Veterinarian Atul Maurya, Faridabad to ANI.

Credit: ANI    Duration: 01:11Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

COVID-19: THESE government employees to be reimbursed for vaccine 'medical expenses'

Government has decided that employees who are insured by United India Insurance Corporation Limited, will be reimbursed the Covid 19 vaccination cost.
DNA
Covid-19 lockdown linked to uptick in tobacco use: Study [Video]

Covid-19 lockdown linked to uptick in tobacco use: Study

A new study has found that pandemic-related anxiety, boredom, and irregular routines were cited as major drivers of increased nicotine and tobacco use during the initial Covid-19 lockdown. The findings of the study were published in the International Journal of Drug Policy. The research was led by Columbia University's Mailman School of Public Health. The study highlighted the ways that public health interventions and policies can better support quit attempts and harm reduction, both during the Covid-19 pandemic and beyond. Decreased use, while less common, was prevalent among "social" tobacco users, who cited fewer interpersonal interactions during the lockdown and a fear of sharing products. At the community level, retail access impacted cigarette and ENDS use differently. While cigarettes were universally accessible in essential businesses, such as convenience stores and gas stations, access to preferred ENDS products was more limited, since "vape shops" and other specialty ENDS retailers were typically deemed non-essential and required to close or limit hours. This drove some ENDS users to order their products online, which often resulted in long wait times due to shipping delays, or product backorder as a result of high demand. As a result, some dual users of cigarettes and ENDS increased their use of readily-available cigarettes.

Credit: ANI    Duration: 01:13Published

Indian Council of Medical Research Indian Council of Medical Research

Covaxin shows 81% efficacy, say ICMR and Bharat Biotech

This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical..
IndiaTimes
'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech [Video]

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.

Credit: ANI    Duration: 01:42Published

PM Modi takes the shot, gives vaccine process a booster dose

The PM, who is 70, was administered Covaxin, the indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research..
IndiaTimes

'Pata hi nahi chala': PM Modi on taking the first shot of COVID-19 vaccine

PM Modi was administered Covaxin, developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research.
DNA
PM Modi takes first vaccine in the second phase, which vaccine did he take? | Oneindia News [Video]

PM Modi takes first vaccine in the second phase, which vaccine did he take? | Oneindia News

Prime Minister Narendra Modi took a Covid shot this morning at Delhi's AIIMS hospital, becoming the first beneficiary in the second phase of nationwide vaccination against the coronavirus. PM Modi took a dose of the home-grown Covaxin developed by Bharat Biotech and the Indian Council of Medical Research. #PMModiGetsVaccine #PMModi #Covid-19

Credit: Oneindia    Duration: 01:01Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Mexico experts recommend approving Indian vaccine

A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company..
IndiaTimes

Delhi high court asks Serum Institute, Bharat Biotech to disclose capacity to manufacture Covid-19 vaccines

"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So..
IndiaTimes
Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News [Video]

Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News

Arvind Kejriwal slams BJP saying the party has failed to govern the municipal corporations in Delhi. Karnataka Minister resigns on moral grounds after tape scandal. Maharashtra Chief Minister Uddhav Thackeray slams BJP and RSS. In a statement made by Bharat Biotech, the biotechnology company claims that the Covaxin is 81 percent effective in preventing Covid and can work against the UK variant of the virus. TMC meets Election Commission over PM's photo on vaccine documents #PMModi #ArvindKejriwal #KarnatakaMinisterSexTape

Credit: Oneindia    Duration: 02:43Published

Related news from verified sources

Haryana Health Minister Anil Vij administered trial dose of Covaxin


newKerala.com - Published Also reported by •IndiaTimesMid-Day



Related videos from verified sources

‘Plan to give Covid vaccine to 25-30 cr people by August 2021’: Harsh Vardhan [Video]

‘Plan to give Covid vaccine to 25-30 cr people by August 2021’: Harsh Vardhan

Union Health Minister Harsh Vardhan on Monday said that the Central government a plan to provide coronavirus vaccines to around 25-30 crore people by July-August next year. "In the first 3-4 months of..

Credit: HT Digital Content     Duration: 01:53Published
25-30 crore Indians could be vaccinated for COVID by Aug 2021: Harsh Vardhan [Video]

25-30 crore Indians could be vaccinated for COVID by Aug 2021: Harsh Vardhan

Union Health Minister Harsh Vardhan on November 30, informed that a COVID-19 vaccine will be provided in first 3-4 months of next year. "In the first 3-4 months of next year, there is a possibility..

Credit: ANI     Duration: 01:13Published
'Delhi Chalo': Haryana govt tried to stop farmers, it has hurt their sentiments, says Hooda [Video]

'Delhi Chalo': Haryana govt tried to stop farmers, it has hurt their sentiments, says Hooda

Former Chief Minister of Haryana Bhupinder S Hooda on November 29 extended his support to Punjab farmers who are protesting against Centre's farm laws. He also said that Centre should let go of their..

Credit: ANI     Duration: 01:38Published